Doug Hampton

Galderma lança aplicativo de realidade aumentada para simulação em tempo real de possíveis efeitos de tratamentos estéticos injetáveis

by

FACE by GaldermaTM está em sua primeira fase de lançamento e já traz dados surpreendentes: 72% dos pacientes que usaram a tecnologia agendaram um procedimento estético injetável após o uso do aplicativo SÃO PAULO, 21 de junho de 2023 /PRNewswire/ — A Galderma, especialista em soluções para cuidados com a pele, que abrange medicamentos de prescrição médica, dermocosméticos … Read more

Lourdes: A congress around sports and rugby medicine

by

the essential The hospital center of Tarbes-Lourdes organizes its annual congress of sports medicine, this Saturday, in Lourdes, around rugby. The cardiology-sports medicine and orthopedic surgery departments of the Tarbes-Lourdes hospital center are organizing their annual sports medicine congress, this Saturday, June 24, from 8:45 a.m. to 1:30 p.m., at the Palais des Congrès in … Read more

Non-insulin Diabetes Therapeutics Market size is set to grow by USD 31,251.55 million from 2022-2027; Increasing number of people with Type 2 diabetes will boost the market- Technavio

by

NEW YORK, June 21, 2023 /PRNewswire/ — The global non-insulin diabetes therapeutics market size is estimated to grow by USD 31,251.55 million from 2022 to 2027. The market is estimated to grow at a CAGR of 10.82%. However, the growth momentum will progress during the forecast period. North America held the largest share of the global market in … Read more

INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC. PRODUCT LINE

by

The Products Include All Molds, Manufacturing, And Registration Rights To AMICI’s Leading Products, Including The “Swirler”, “UltraShield”, and “Tru-Fit” Mouth Piece IDAHO FALLS, Idaho, June 21, 2023 /PRNewswire/ — International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that it has acquired the manufacturing molds, device registrations, trademarks, and all production … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

by

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

by

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

Yoga is (also) effective in improving running performance

by

(ETX Daily Up) – A true anti-stress, yoga is known to improve flexibility, tone, and breathing. But we know less that it helps to prepare for the effort and to prevent certain injuries. These are the foundations of ‘yog’n’run’, an activity that combines breathing exercises, muscle strengthening and mental preparation. On the occasion of International … Read more

With a beer, a goat or a dog: yoga is transformed into a discipline as effective as it is unusual

by

(ETX Daily Up) – How about exercising with your pet? The idea may make you smile, and yet it has been taking shape for several months in the form of ‘doga’, ‘dog yoga’, ‘cat yoga’, or ‘puppy yoga’ classes. So many names that simply translate into yoga sessions surrounded by animals, a variant with multiple … Read more

Canopy Growth to Report Fourth Quarter and Fiscal Year 2023 Financial Results on June 22, 2023

by

SMITHS FALLS, ON, June 21, 2023 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2023 ended March 31, 2023, and file the Company’s comprehensive annual report on Form 10-K for the fiscal years ended March 31, 2023 … Read more